$PALI
PALISADE BIO, INC.

2017 Q4 Form 10-K Financial Statement

#000117184318002404 Filed on April 02, 2018

View on sec.gov

Income Statement

Concept 2017 Q4 2017 2016 Q4
Revenue $250.0K $260.0K $10.00K
YoY Change 2400.0% 1500.39% 300.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.300M $5.470M $1.630M
YoY Change -20.25% -27.07% 1.88%
% of Gross Profit
Research & Development $1.230M $8.096M $4.030M
YoY Change -69.48% -38.46% 46.55%
% of Gross Profit
Depreciation & Amortization $60.00K $100.0K $60.00K
YoY Change 0.0% -37.89% -33.33%
% of Gross Profit
Operating Expenses $2.520M $13.57M $5.660M
YoY Change -55.48% -34.31% 30.11%
Operating Profit -$13.31M
YoY Change -35.52%
Interest Expense -$1.050M $159.1K $270.0K
YoY Change -488.89% -86.06% -164.29%
% of Operating Profit
Other Income/Expense, Net $10.00K -$2.359M -$10.00K
YoY Change -200.0% 438.84% -200.0%
Pretax Income -$3.320M -$15.67M -$5.400M
YoY Change -38.52% -25.63% 13.21%
Income Tax
% Of Pretax Income
Net Earnings -$3.320M -$15.67M -$5.400M
YoY Change -38.52% -25.66% 13.21%
Net Earnings / Revenue -1328.0% -6025.38% -54000.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$25.54M -$142.5M -$67.50M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q4 2017 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.67M $11.67M $20.19M
YoY Change -42.2% -42.2% 65.09%
Cash & Equivalents $6.675M $6.670M $15.19M
Short-Term Investments $5.000M $5.000M $5.000M
Other Short-Term Assets $400.0K $400.0K $650.0K
YoY Change -38.46% -38.46% -43.97%
Inventory
Prepaid Expenses $402.3K $646.2K
Receivables $312.8K $310.0K $10.49K
Other Receivables $60.00K $60.00K $50.00K
Total Short-Term Assets $12.45M $12.45M $20.90M
YoY Change -40.45% -40.43% 55.64%
LONG-TERM ASSETS
Property, Plant & Equipment $172.9K $170.0K $269.6K
YoY Change -35.86% -37.04% -21.46%
Goodwill
YoY Change
Intangibles $883.5K $990.2K
YoY Change -10.78% -10.27%
Long-Term Investments
YoY Change
Other Assets $13.85K $10.00K $15.66K
YoY Change -11.55% -50.0% -78.19%
Total Long-Term Assets $1.436M $1.430M $1.700M
YoY Change -15.53% -15.88% 11.93%
TOTAL ASSETS
Total Short-Term Assets $12.45M $12.45M $20.90M
Total Long-Term Assets $1.436M $1.430M $1.700M
Total Assets $13.88M $13.88M $22.60M
YoY Change -38.58% -38.58% 51.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $880.0K $880.0K $2.340M
YoY Change -62.39% -62.39% 60.27%
Accrued Expenses $420.0K $420.0K $850.0K
YoY Change -50.59% -50.59% 431.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $3.706M
YoY Change -100.0% -18.47%
Total Short-Term Liabilities $1.515M $1.510M $7.333M
YoY Change -79.35% -79.4% 14.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.850M $3.850M $3.940M
YoY Change -2.28% -2.28% 2217.65%
Total Long-Term Liabilities $3.850M $3.850M $0.00
YoY Change -2.28% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.515M $1.510M $7.333M
Total Long-Term Liabilities $3.850M $3.850M $0.00
Total Liabilities $5.369M $5.370M $11.27M
YoY Change -52.37% -52.35% 12.94%
SHAREHOLDERS EQUITY
Retained Earnings -$208.7M -$193.0M
YoY Change 8.12% 12.26%
Common Stock $151.6K $110.3K
YoY Change 37.41% 55.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.515M $8.520M $11.33M
YoY Change
Total Liabilities & Shareholders Equity $13.88M $13.88M $22.60M
YoY Change -38.58% -38.58% 51.2%

Cashflow Statement

Concept 2017 Q4 2017 2016 Q4
OPERATING ACTIVITIES
Net Income -$3.320M -$15.67M -$5.400M
YoY Change -38.52% -25.66% 13.21%
Depreciation, Depletion And Amortization $60.00K $100.0K $60.00K
YoY Change 0.0% -37.89% -33.33%
Cash From Operating Activities -$2.290M -$13.42M -$4.080M
YoY Change -43.87% -14.09% 4.62%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $11.40K -$30.00K
YoY Change -100.0% -88.38% -40.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$5.000M
YoY Change -100.0% -100.0% 100.0%
Cash From Investing Activities $0.00 -$94.05K -$5.030M
YoY Change -100.0% -103.99% 97.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $3.766M
YoY Change -17.59%
Cash From Financing Activities -100.0K 4.991M 18.63M
YoY Change -100.54% -78.98% -1050.51%
NET CHANGE
Cash From Operating Activities -2.290M -13.42M -4.080M
Cash From Investing Activities 0.000 -94.05K -5.030M
Cash From Financing Activities -100.0K 4.991M 18.63M
Net Change In Cash -2.390M -8.519M 9.520M
YoY Change -125.11% -181.3% -213.2%
FREE CASH FLOW
Cash From Operating Activities -$2.290M -$13.42M -$4.080M
Capital Expenditures $0.00 $11.40K -$30.00K
Free Cash Flow -$2.290M -$13.43M -$4.050M
YoY Change -43.46% -14.55% 5.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 cur Accounts Payable And Accrued Expenses Excluding Accrued Bonuses
AccountsPayableAndAccruedExpensesExcludingAccruedBonuses
875065
CY2016Q4 cur Accounts Payable And Accrued Expenses Excluding Accrued Bonuses
AccountsPayableAndAccruedExpensesExcludingAccruedBonuses
2343936
CY2017 cur Expenses Related To Issuance Of Derivative Instrument
ExpensesRelatedToIssuanceOfDerivativeInstrument
242676
CY2016 cur Expenses Related To Issuance Of Derivative Instrument
ExpensesRelatedToIssuanceOfDerivativeInstrument
466541
CY2017 cur Expenses Related To The Inducement Of Warrants
ExpensesRelatedToTheInducementOfWarrants
563744
CY2016 cur Expenses Related To The Inducement Of Warrants
ExpensesRelatedToTheInducementOfWarrants
CY2017 cur Fees Related To Issuance Of Derivative Instrument And Other Expenses
FeesRelatedToIssuanceOfDerivativeInstrumentAndOtherExpenses
799907
CY2016 cur Fees Related To Issuance Of Derivative Instrument And Other Expenses
FeesRelatedToIssuanceOfDerivativeInstrumentAndOtherExpenses
474167
CY2017 cur Nonoperating Gains Losses Related Party Settlement
NonoperatingGainsLossesRelatedPartySettlement
CY2016 cur Nonoperating Gains Losses Related Party Settlement
NonoperatingGainsLossesRelatedPartySettlement
458608
CY2017Q4 cur Operating Leases Future Minimum Payments Due After Four Years
OperatingLeasesFutureMinimumPaymentsDueAfterFourYears
CY2017 cur Proceeds From Exercise Of Stock Purchase Warrants Net Of Issuance Costs
ProceedsFromExerciseOfStockPurchaseWarrantsNetOfIssuanceCosts
3225176
CY2016 cur Proceeds From Exercise Of Stock Purchase Warrants Net Of Issuance Costs
ProceedsFromExerciseOfStockPurchaseWarrantsNetOfIssuanceCosts
CY2017Q3 cur Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts
5414000
CY2017 cur Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts
5510840
CY2016 cur Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts
28118962
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
724771
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2631
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3905
CY2017 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P9Y328D
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
217050174
CY2016 cur Stock And Warrants Issued During Period From Capital Raises Value Net
StockAndWarrantsIssuedDuringPeriodFromCapitalRaisesValueNet
23991738
CY2017 cur Stock And Warrants Issued During Period From Capital Raises Value Net
StockAndWarrantsIssuedDuringPeriodFromCapitalRaisesValueNet
3269667
CY2017 cur Stock Issued During Period Value From Warrants Exercised
StockIssuedDuringPeriodValueFromWarrantsExercised
7811977
CY2016 cur Stock Issued During Period Value Rsu And Option Exercises Net Of Forfeitures
StockIssuedDuringPeriodValueRSUAndOptionExercisesNetOfForfeitures
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
312802
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10491
CY2017Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
418625
CY2016Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
852963
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
821925
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
204239837
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3445539
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1769964
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1769964
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3445539
CY2017 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
59781
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
347491
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
189000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
176000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10200000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8700000
CY2017 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2017Q4 us-gaap Assets
Assets
13884456
CY2016Q4 us-gaap Assets
Assets
22604328
CY2017Q4 us-gaap Assets Current
AssetsCurrent
12448799
CY2016Q4 us-gaap Assets Current
AssetsCurrent
20904716
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6674940
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8520009
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10478416
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15194949
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4716533
CY2017Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
11700000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15160014
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11032858
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15160014
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11032858
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
151600
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
110329
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15667257
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21073777
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2017Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2017Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1.229
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.332
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
1.55
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.042
CY2017 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y292D
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
926000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-17837120
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-5626995
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-19254602
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6810088
CY2017 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
19254602
CY2016 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
6810088
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1417482
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1183093
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
43487600
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
62742202
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
35610806
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
51249822
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
1112286
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
1373979
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6764508
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
10118401
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43487600
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
62742202
CY2017 us-gaap Depreciation
Depreciation
100000
CY2016 us-gaap Depreciation
Depreciation
161000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
289208
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
337508
CY2017 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1470174
CY2016 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
660253
CY2017Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3852882
CY2016Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3921917
CY2017Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
58784
CY2016Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
53081
CY2017Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
365456
CY2016Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
424240
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.20
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.53
CY2017 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-579
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-543
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.002
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.076
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.058
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.026
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.041
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
4582170
CY2015Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3921917
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1145095
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-660253
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
960670
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
88000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
88000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
88000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
88000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
88000
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2028557
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1950823
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
883462
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
990153
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8128
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-10284
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5471010
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7497202
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13884456
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1522917
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
879076
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
302311
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-26825
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-434338
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
691601
CY2017 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-53081
CY2016 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
477321
CY2017 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-230189
CY2016 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-21672
CY2017 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1855
CY2016 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-55663
CY2017 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-16333
CY2016 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-155935
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-297298
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-513156
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
883462
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
990153
CY2017 us-gaap Interest Expense
InterestExpense
159066
CY2016 us-gaap Interest Expense
InterestExpense
1141297
CY2017 us-gaap Interest Paid Net
InterestPaidNet
118257
CY2016 us-gaap Interest Paid Net
InterestPaidNet
990857
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
70269
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
58835
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
161000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
243000
CY2017Q4 us-gaap Liabilities
Liabilities
5369327
CY2016Q4 us-gaap Liabilities
Liabilities
11273550
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22604328
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1514569
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7333424
CY2017Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
1876
CY2016Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
18209
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3705787
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4990778
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23738728
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-94046
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2356339
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13416162
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15616108
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-21074611
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-15665983
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2358878
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-437768
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017 us-gaap Operating Expenses
OperatingExpenses
13567105
CY2016 us-gaap Operating Expenses
OperatingExpenses
20653089
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-13307105
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-20636843
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
337000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
240000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
97000
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
146400000
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
133600000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13853
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15662
CY2016 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
834
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1274
CY2017 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1274
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
834
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
220879
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
430738
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
82645
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
63026
CY2017 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5000000
CY2016 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5000000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11401
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
98088
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
402273
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
646195
CY2017Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
6000000
CY2017 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
5000000
CY2016 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
7517453
CY2017 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
346863
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y292D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2016 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
313483
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
994811
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
994328
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
172886
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
269557
CY2017 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3765568
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4569540
CY2017 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
326533
CY2016 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
124177
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8096095
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13155887
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-208699276
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-193033293
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.18
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
108000
CY2017 us-gaap Revenues
Revenues
260000
CY2016 us-gaap Revenues
Revenues
16246
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1691987
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1894077
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1769964
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
3445539
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
6900000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1576364
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
22.92
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
44892
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
246982
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.34
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
22.60
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.76
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
28.67
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.92
CY2017Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1894077
CY2017Q3 us-gaap Share Price
SharePrice
2
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y255D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
302000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2643000
CY2017Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
19.76
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y36D
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
5000000
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
5000000
CY2017 us-gaap Stock Issued1
StockIssued1
CY2016 us-gaap Stock Issued1
StockIssued1
8936
CY2017Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3000000
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
4967278
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
11330778
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
8515129
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The consolidated financial statements include significant estimates for the expected economic life and value of our licensed technology and related patents, our net operating loss and related valuation allowance for tax purposes, the fair value of our liability classified warrants and our share-based compensation related to employees and directors, consultants and advisors, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates.</div></div></div></div></div></div></div></div></div></div>
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13064422
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8345992

Files In Submission

Name View Source Status
0001171843-18-002404-index-headers.html Edgar Link pending
0001171843-18-002404-index.html Edgar Link pending
0001171843-18-002404.txt Edgar Link pending
0001171843-18-002404-xbrl.zip Edgar Link pending
clinical.jpg Edgar Link pending
cpfq_cgii.jpg Edgar Link pending
cur-20171231.xml Edgar Link completed
cur-20171231.xsd Edgar Link pending
cur-20171231_cal.xml Edgar Link unprocessable
cur-20171231_def.xml Edgar Link unprocessable
cur-20171231_lab.xml Edgar Link unprocessable
cur-20171231_pre.xml Edgar Link unprocessable
exh_1401.htm Edgar Link pending
exh_2301.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10k_031518p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fugl.jpg Edgar Link pending
madrs_sdq.jpg Edgar Link pending
nsi566.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending